跳到主要內容

Kelsey Stephen Michael 的 Form 4 申報

Revolution Medicines, Inc.RVMD,2026/11/18 申報

申報編號
0001193125-26-467372
申報時間
2026/11/18 18:23 ET
交易日
2026/11/16
申報延遲
2 天
10b5-1 計畫
有勾選

這份申報列了 7 筆非衍生性交易、1 筆衍生性交易。公開市場賣出合計 $455.9 萬。交易後 2 天申報。

申報人

一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人與公司的關係
Kelsey Stephen MichaelCIK 0001462808高階主管(見申報備註)

非衍生性證券(表 I)

普通股等股票的取得與處分,每一列是申報上的一筆。

非衍生性證券的交易
交易日證券交易股數價格金額交易後持股持有方式旗標
2026/11/16Common StockM行使選擇權取得+27,160$18.56+$504,089.6313,467直接
2026/11/16Common StockS賣出處分−11,542$166.75F2−$1,924,635.43301,925直接
2026/11/16Common StockS賣出處分−3,627$167.66F3−$608,109.71298,298直接
2026/11/16Common StockS賣出處分−8,039$168.64F4−$1,355,676.86290,259直接
2026/11/16Common StockS賣出處分−3,052$169.46F5−$517,180.02287,207直接
2026/11/16Common StockS賣出處分−700$170.40F6−$119,276.99286,507直接
2026/11/16Common StockS賣出處分−200$171.65−$34,330286,307直接

衍生性證券(表 II)

選擇權、認股權證、限制型股票單位等。股數是標的股票的股數;單價與金額是衍生證券本身的價格,交易後持有是衍生證券的單位數。

衍生性證券的交易
交易日證券交易標的股數單價金額交易後持有持有方式旗標
2026/11/16Common StockM行使選擇權處分−27,160$0.00$0108,640直接

附註與備註

本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。

F2

The transaction was executed in multiple trades at prices ranging from $166.14 to $167.13, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

表 I 有 1 筆交易的價格引用這則附註。

F3

The transaction was executed in multiple trades at prices ranging from $167.14 to $168.13, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

表 I 有 1 筆交易的價格引用這則附註。

F4

The transaction was executed in multiple trades at prices ranging from $168.15 to $169.13, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

表 I 有 1 筆交易的價格引用這則附註。

F5

The transaction was executed in multiple trades at prices ranging from $169.15 to $170.09, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

表 I 有 1 筆交易的價格引用這則附註。

F6

The transaction was executed in multiple trades at prices ranging from $170.22 to $170.63, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

表 I 有 1 筆交易的價格引用這則附註。

備註

Senior Advisor to the Chief Executive Officer

看 SEC EDGAR 上的完整原文 (在新分頁開啟)